Mural Oncology plc (MURA)
Dec 5, 2025 - MURA was delisted (reason: acquired by XOMA)
2.040
0.00 (0.00%)
Inactive · Last trade price on Dec 4, 2025
Mural Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 58.87 | 115.46 | 270.85 | - | - |
Short-Term Investments | - | 28.92 | - | - | - |
Cash & Short-Term Investments | 58.87 | 144.39 | 270.85 | - | - |
Cash Growth | -66.45% | -46.69% | - | - | - |
Other Receivables | - | 0.45 | 6.34 | 1.8 | 2 |
Receivables | - | 0.45 | 6.34 | 1.8 | 2 |
Prepaid Expenses | 1.21 | 7.68 | 0.15 | 2.99 | 2.2 |
Other Current Assets | 0.36 | 0.41 | - | 0.03 | 0.04 |
Total Current Assets | 62.16 | 152.92 | 277.34 | 4.82 | 4.24 |
Property, Plant & Equipment | 3.6 | 14.5 | 24.15 | 28.93 | 30.87 |
Other Long-Term Assets | - | 1.98 | 0.26 | - | - |
Total Assets | 65.76 | 169.39 | 301.75 | 33.75 | 35.11 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 2.06 | 5.97 | 2.97 | 10.59 |
Accrued Expenses | 6.79 | 18.53 | 16.95 | 32.75 | 16.74 |
Current Portion of Leases | 3.51 | 5.56 | 6.1 | 5.84 | 5.92 |
Other Current Liabilities | 0.24 | 0.05 | - | - | - |
Total Current Liabilities | 10.53 | 26.2 | 29.02 | 41.56 | 33.25 |
Long-Term Leases | 0.04 | 2.46 | 8.91 | 13.54 | 19.39 |
Other Long-Term Liabilities | - | 0.24 | - | 0.3 | 0.36 |
Total Liabilities | 10.57 | 28.89 | 37.93 | 55.41 | 52.99 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.17 | 0.17 | 0.17 | -21.66 | -17.88 |
Additional Paid-In Capital | 299.21 | 299.68 | 294.51 | - | - |
Retained Earnings | -244.2 | -159.37 | -30.86 | - | - |
Comprehensive Income & Other | - | 0.02 | - | - | - |
Shareholders' Equity | 55.19 | 140.5 | 263.82 | -21.66 | -17.88 |
Total Liabilities & Equity | 65.76 | 169.39 | 301.75 | 33.75 | 35.11 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.55 | 8.02 | 15.01 | 19.39 | 25.31 |
Net Cash (Debt) | 55.32 | 136.36 | 255.84 | -19.39 | -25.31 |
Net Cash Growth | -66.66% | -46.70% | - | - | - |
Net Cash Per Share | 3.21 | 8.04 | 15.33 | -1.16 | - |
Filing Date Shares Outstanding | 17.34 | 17.23 | 16.92 | 16.69 | - |
Total Common Shares Outstanding | 17.32 | 17.1 | 16.69 | 16.69 | - |
Working Capital | 51.63 | 126.72 | 248.32 | -36.74 | -29.01 |
Book Value Per Share | 3.19 | 8.22 | 15.81 | -1.30 | - |
Tangible Book Value | 55.19 | 140.5 | 263.82 | -21.66 | -17.88 |
Tangible Book Value Per Share | 3.19 | 8.22 | 15.81 | -1.30 | - |
Machinery | 9.57 | 21.51 | 21.74 | 17.47 | 13.6 |
Construction In Progress | - | - | 0.02 | 1.99 | 1.97 |
Leasehold Improvements | 23.23 | 23.23 | 23.33 | 22.51 | 20.88 |